C50.3
Malignant neoplasm of lower-inner quadrant of breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the lower-inner quadrant of the breast, classified under ICD-10 code C50.3, refers to a type of breast cancer located in the lower-inner section of the breast. This form of cancer involves abnormal, uncontrolled growth of cells within the breast tissue, which can potentially spread to other parts of the body if not diagnosed and treated early. Understanding this condition is pivotal for early detection, effective management, and improving the prognosis for individuals affected.
Causes & Symptoms
Clinical Causes: Genetic mutations that influence cell growth and division Family history of breast cancer or other genetic predispositions Hormonal factors, such as prolonged exposure to estrogen Environmental exposures, including radiation or carcinogenic chemicals Lifestyle factors like alcohol consumption, obesity, and physical inactivity Previous history of breast cancer or certain benign breast diseases
Key Symptoms: A lump or mass in the lower-inner part of the breast Change in the size, shape, or appearance of the breast Skin changes over the affected area, such as redness or dimpling Nipple changes, including inversion or discharge Persistent pain or discomfort not related to the menstrual cycle Swelling or a palpable thickening in the breast tissue
Diagnostic & Treatment
Diagnosis Path: Clinical breast examination performed by a healthcare provider Imaging studies such as mammography and ultrasound to visualize the tumor Biopsy procedures, including fine needle aspiration or core biopsy, to obtain tissue samples for microscopic analysis Magnetic resonance imaging (MRI) may be used to assess the extent of the tumor Additional tests like CT scans or bone scans could be performed to check for metastasis
Treatment Protocols: Surgery, such as lumpectomy or mastectomy, to remove the tumor and affected tissue Radiation therapy to destroy residual cancer cells post-surgery Chemotherapy, utilizing drugs to target cancer cells throughout the body Hormonal therapy to block hormones that fuel some types of breast cancer Targeted therapy designed to attack specific molecules involved in cancer growth Immunotherapy, which boosts the immune system's ability to fight cancer
Clinical Advice & FAQs
Billing Guidance
Is C50.3 a billable ICD-10 code?
Yes, C50.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.3?
Clinical documentation must specify the nature of Malignant neoplasm of lower-inner quadrant of breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference